EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterization of GUA-1, a chromosomally encoded ESBL from Pseudomonas guariconensis-like

Saoussen Oueslati, Nadia Jaidane, Reva Nermont, Delphine Girlich, Nahed Al Laham, Lamia Tilouche, Wejdene Mansour, Marisa Haenni, Bogdan I Iorga iD, Thierry Naas iD

Antimicrobial Agents and Chemotherapy · 05.08.2026 · 70 (8)

DOI: 10.1128/aac.00126-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 05.08.2026. Verfasst von Saoussen Oueslati und 9 weiteren Autor:innen. Beteiligte Einrichtung: Team 'Resist', UMR1184 IDMIT (INSERM, Université Paris-Saclay, CEA), Faculty of Medicine, Le Kremlin-Bicêtre, France. Hauptthemen laut MEDLINE: beta-Lactamases, Pseudomonas, Chromosomes, Bacterial, Bacterial Proteins. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche, Institut National de la Santé et de la Recherche Médicale, Assistance Publique-Hôpitaux de Paris.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Putative novel β-lactamase-encoding genes are increasingly identified in whole-genome sequencing (WGS) data, often without phenotypic or biochemical characterization. Here, we characterized the chromosome-encoded GUA-1 Ambler class A β-lactamase from the clinical isolate Pseudomonas guariconensis-like 65411. Among the 40 P. guariconensis genomes available in the GenBank database, only 8 carried a bla GUA-like gene, whereas the others encoded an AmpC β-lactamase, suggesting the existence of two distinct subspecies. Notably, these eight isolates, despite originating from diverse geographical regions, all harbored the bla GUA-like gene inserted at the same chromosomal locus. Heterologous expression in Pseudomonas aeruginosa and Escherichia coli revealed a clavulanic-acid-inhibited cefotaximase-type ESBL. GUA-1 shared 72% amino acid sequence identity with putative Ambler class A β-lactamases from Pseudomonas fulva , Pseudomonas mosselii , and Pseudomonas soli , and 57% with LUT-1, a class A cephalosporinase from Pseudomonas luteola . Kinetic analyses showed that GUA-1 hydrolyzed cefotaxime but not ceftazidime, similarly to LUT-1 and CTX-M-1-type ESBLs. IC 50 measurements indicated strong inhibition by clavulanic acid, tazobactam, and avibactam, but not by vaborbactam. Molecular modeling supported these findings, showing favorable binding of cefotaxime in the active site, whereas steric hindrance from Trp274 and electrostatic repulsion from Asp240 likely prevent ceftazidime binding. The bla GUA-1 gene was chromosomally located, with no obvious promoter identified in the immediate upstream region. RT-PCR experiments revealed expression levels comparable to other β-lactamase genes present ( bla DHA , bla CMY , bla OXA-1 , and bla OXA-204 ) and to the upstream-located Na+/H antiporter gene. 5′ RACE experiments suggested that the bla GUA-1 gene is co-transcribed along with the Na+/H gene. Overall, this study highlights the diversity of β-lactamases within Pseudomonas species.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-LactamasesPseudomonasChromosomes, BacterialBacterial ProteinsAnti-Bacterial AgentsClavulanic AcidMicrobial Sensitivity TestsPseudomonas aeruginosaEscherichia coliThird Generation CephalosporinsCefotaximeTazobactam

Stichwörter der Autor:innen

Pseudomonas spcephalosporinaseclass Aextended spectrum beta-lactamase

Substanzen

beta-LactamasesAnti-Bacterial AgentsClavulanic AcidBacterial ProteinsThird Generation CephalosporinsCefotaximeTazobactam

Autor:innen und Institutionen

  • Team 'Resist', UMR1184 IDMIT (INSERM, Université Paris-Saclay, CEA), Faculty of Medicine, Le Kremlin-Bicêtre, France.
  • Department of Bacteriology-Hygiene, Bicêtre Hospital, APHP Paris-Saclay, Le Kremlin-Bicêtre, France.
  • Laboratory of Metabolic Biophysics and Applied Pharmacology (LR12ES02), Department of Biophysics, Faculty of Medicine Ibn El Jazzar of Sousse, University of Sousse, Sousse, Tunisia.
  • Clinical Microbiology Laboratory, University Hospital of Sahloul, Sousse, Tunisia.
  • Laboratory Medicine Department, Faculty of Applied Medical Sciences, Al Azhar University-Gaza, Gaza, Palestine.
  • ANSES-Université de Lyon, Unité Antibiorésistance et Virulence Bactériennes, Lyon, France.

ORCID-Profile: Bogdan I Iorga, Thierry Naas

Förderung

  • Agence Nationale de la Recherche
  • Institut National de la Santé et de la Recherche Médicale
  • Assistance Publique-Hôpitaux de Paris
  • Université Paris-Saclay
  • Tunisian Ministry of Higher Education

Zitieren

APA

Oueslati, S., Jaidane, N., Nermont, R., Girlich, D., Al Laham, N., Tilouche, L., Mansour, W., Haenni, M., Iorga, B. I., & Naas, T. (2026). Characterization of GUA-1, a chromosomally encoded ESBL from Pseudomonas guariconensis-like. Antimicrobial Agents and Chemotherapy, 70(8). https://doi.org/10.1128/aac.00126-26

Vancouver

Oueslati S, Jaidane N, Nermont R, Girlich D, Al Laham N, Tilouche L, et al. Characterization of GUA-1, a chromosomally encoded ESBL from Pseudomonas guariconensis-like. Antimicrobial Agents and Chemotherapy. 2026;70(8). doi:10.1128/aac.00126-26

BibTeX
@article{Oueslati2026,
  author = {Oueslati, Saoussen and Jaidane, Nadia and Nermont, Reva and Girlich, Delphine and Al Laham, Nahed and Tilouche, Lamia and Mansour, Wejdene and Haenni, Marisa and Iorga, Bogdan I and Naas, Thierry},
  title = {Characterization of GUA-1, a chromosomally encoded ESBL from Pseudomonas guariconensis-like},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  volume = {70},
  number = {8},
  doi = {10.1128/aac.00126-26}
}
Kostenlos starten →